Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients.

We constructed and validated a prognostic model based on MRS and clinical prognostic factors to predict the OS of EC patients accurately, which may help clinicians personalize prognostic assessments and effective clinical decisions.